Home / Street Sector / Active Broker’s Choice: DR Horton Inc. (NYSE:DHI), Allegheny Technologies Inc. (NYSE:ATI)

Active Broker’s Choice: DR Horton Inc. (NYSE:DHI), Allegheny Technologies Inc. (NYSE:ATI)

DR Horton Inc. (NYSE:DHI) [Trend Analysis] plunged reacts as active mover, shares a loss -0.66% to traded at $30.27 and the percentage gap between open changing to regular change was -0.98%. Finally to see some strong financial remarks by WSJ over DHI performance. Out of the pool of analysts 5 gave their BUY ratings on the stock in previous month as 6″ Analysts having BUY in current month. Majority ranked Overweight from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $0.76 while one month ago this estimate trend was for $0.76. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $2.68 and for the one month was for $2.68 as compared to three months ago was for $2.67. Whereas, DHI received highest price target of 38.00 and low target of 28.00. The stock price target chart showed average price target of 34.89 as compared to current price of 29.97.

The firm past twelve months price to sales ratio was 1.02 and price to cash ratio remained 13.06. As far as the returns are concern, the return on equity was recorded as 13.60% and return on investment was 7.70% while its return on asset stayed at 7.50%. The firm has total debt to equity ratio measured as 0.51.

Allegheny Technologies Inc. (NYSE:ATI) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.94% to close at $15.79 with the total traded volume of 281475 shares. The firm has institutional ownership of 95.90%, while insider ownership included 0.30%. Its price to sales ratio ended at 0.61. ATI attains analyst recommendation of 2.40 with week performance of -11.20%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Stock Revamps on Eco Changes: Rigel Pharmaceuticals (NASDAQ:RIGL), JPMorgan Chase & Co. (NYSE:JPM)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) [Trend Analysis] knocking active thrust in leading trading session, shares a decrease …

Leave a Reply

Your email address will not be published. Required fields are marked *